HYPERPHOSPHATEMIA
Clinical trials for HYPERPHOSPHATEMIA explained in plain language.
Never miss a new study
Get alerted when new HYPERPHOSPHATEMIA trials appear
Sign up with your email to follow new studies for HYPERPHOSPHATEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for dialysis patients: drug AP301 targets dangerous phosphate levels
Disease control Recruiting nowThis study tests a new drug called AP301 to see if it can safely lower high blood phosphate levels in people with kidney failure who are on dialysis. About 264 adults and teens will take either AP301 or a low-dose version for 8 weeks, then all receive AP301 for 24 weeks. The goal…
Matched conditions: HYPERPHOSPHATEMIA
Phase: PHASE3 • Sponsor: Alebund Pharmaceuticals • Aim: Disease control
Last updated May 19, 2026 11:46 UTC
-
Massive study aims to find safe drug doses for kids
Knowledge-focused Recruiting nowThis study looks at how certain medicines act in the bodies of children and young adults under 21. Researchers want to find the safest and most effective doses for these age groups. Participants are already receiving these drugs as part of their normal care. No new treatments are…
Matched conditions: HYPERPHOSPHATEMIA
Sponsor: Duke University • Aim: Knowledge-focused
Last updated May 19, 2026 11:47 UTC